You are here

Article Text

Article menu
Download PDFPDF
Community child health, public health, and epidemiology
Long term effects of long chain polyunsaturated fats in hyperphenylalaninemic children
  1. C Agostoni1,
  2. E Verduci1,
  3. N Massetto2,
  4. L Fiori1,
  5. G Radaelli3,
  6. E Riva1,
  7. M Giovannini1
  1. 1Department of Pediatrics, San Paolo Hospital, University of Milan, Milan, Italy
  2. 2Department of Neurology, San Paolo Hospital
  3. 3Unit of Medical Statistics, San Paolo Hospital
  1. Correspondence to:
    Dr C Agostoni, Department of Pediatrics, San Paolo Hospital, 8 Via A. di Rudinì, I-20142 Milano, Italy; e-mail:
    agostoc{at}tin.it

Abstract

Blood fatty acid status and visual function of 20 treated hyperphenylalaninemic (HPA) children, randomly allocated into two groups to receive supplementation of either long chain polyunsaturated fatty acids (LCPUFA), including docosahexaenoic acid (DHA), or placebo for 12 months, have been investigated three years after the end of the treatment. Although in the LCPUFA group blood DHA levels and P100 wave latency improved at the end of supplementation, they had returned to baseline after three years.

  • diet
  • docosahexaenoic acid
  • hyperphenylalaninemic
  • long chain polyunsaturated fatty acids
  • CE, cholesterol esters
  • DHA, docosahexaenoic acid
  • Ery, erythrocyte total lipids
  • EryPE, phosphatidylethanolamine
  • HPA, hyperphenylalaninemic
  • LCPUFA, long chain polyunsaturated fatty acids
  • Phe, phenylalanine
  • PL, phospholipids
  • TG, triglycerides
  • TL, total lipids
  • VEP, visual evoked potential

https://doi.org/10.1136/adc.88.7.582

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes